Although effective against other rheumatic diseases, disease-modifying antirheumatic drugs (DMARDs), such as sulfasalazine and methotrexate, seem to be less beneficial in treating the axial ...

EST Beyond Meat (BYND) sees Q1 revenue comparable to last yearDiscover the Best Stocks and Maximize Your Portfolio: See what stocks are ...

Bridgewater Associates Chief Executive Officer Nir Bar Dea said a fund it launched last year that uses machine learning and AI to make decisions has delivered performance that’s “comparable ...